Development and Initial Assessment of the Medication User Self-Evaluation (MUSE) Tool

William R. Doucette, Elizabeth H. Chang, Jane F. Pendergast, Kara B. Wright, Elizabeth A. Chrischilles, Karen B. Farris

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Using patient-reported data to supplement claims-based indicators may be helpful in identifying Medicare beneficiaries likely to benefit from medication therapy management (MTM) services. Objective: Our objective was to develop and initially assess a patient medication user self-evaluation (MUSE) tool to identify Medicare Part D beneficiaries who would benefit from a comprehensive medication review. Methods: A random sample of 225 patient medication profiles was created from a survey of Medicare beneficiaries; the survey also included demographic characteristics, responses to adherence questions, and reported symptoms. Three clinical pharmacists used the patient profiles to make judgments regarding the likelihood (low, moderate, or high) that each patient would benefit from an MTM visit in the next 3 months. A total of 150 cases were used for model calibration, and 75 were used for validation. Ordinal logistic regression models were fit to predict the likelihood of benefit from an MTM visit by using different combinations of potential MUSE items. Final model selection was based on the Akaike information criterion and the percent agreement between model prediction and expert judgments in the validation data. Measures considered for inclusion in the MUSE tool were related to medication use, medical conditions, and health care utilization. Results: The final MUSE items incorporated number of medications, number of physicians, number of pharmacies, number of hospitalizations in the past 6 months, having forgotten to take medications, cost-related problems, and number of medical conditions. Conclusion: The 7-item MUSE tool could be used in targeting MTM services, such as comprehensive medication reviews, among Medicare beneficiaries.

Original languageEnglish
Pages (from-to)344-350
Number of pages7
JournalClinical Therapeutics
Volume35
Issue number3
DOIs
Publication statusPublished - Mar 2013
Externally publishedYes

Fingerprint

Diagnostic Self Evaluation
Medication Therapy Management
Medicare
Medicare Part D
Logistic Models
Patient Acceptance of Health Care
Pharmacies
Pharmacists
Calibration
Hospitalization
Demography
Physicians
Costs and Cost Analysis

Keywords

  • Comprehensive medication review
  • Medicare
  • Medication therapy management
  • Tool

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Doucette, W. R., Chang, E. H., Pendergast, J. F., Wright, K. B., Chrischilles, E. A., & Farris, K. B. (2013). Development and Initial Assessment of the Medication User Self-Evaluation (MUSE) Tool. Clinical Therapeutics, 35(3), 344-350. https://doi.org/10.1016/j.clinthera.2013.02.010

Development and Initial Assessment of the Medication User Self-Evaluation (MUSE) Tool. / Doucette, William R.; Chang, Elizabeth H.; Pendergast, Jane F.; Wright, Kara B.; Chrischilles, Elizabeth A.; Farris, Karen B.

In: Clinical Therapeutics, Vol. 35, No. 3, 03.2013, p. 344-350.

Research output: Contribution to journalArticle

Doucette, WR, Chang, EH, Pendergast, JF, Wright, KB, Chrischilles, EA & Farris, KB 2013, 'Development and Initial Assessment of the Medication User Self-Evaluation (MUSE) Tool', Clinical Therapeutics, vol. 35, no. 3, pp. 344-350. https://doi.org/10.1016/j.clinthera.2013.02.010
Doucette, William R. ; Chang, Elizabeth H. ; Pendergast, Jane F. ; Wright, Kara B. ; Chrischilles, Elizabeth A. ; Farris, Karen B. / Development and Initial Assessment of the Medication User Self-Evaluation (MUSE) Tool. In: Clinical Therapeutics. 2013 ; Vol. 35, No. 3. pp. 344-350.
@article{5af35873a64447eeb7f0409a479a07f5,
title = "Development and Initial Assessment of the Medication User Self-Evaluation (MUSE) Tool",
abstract = "Background: Using patient-reported data to supplement claims-based indicators may be helpful in identifying Medicare beneficiaries likely to benefit from medication therapy management (MTM) services. Objective: Our objective was to develop and initially assess a patient medication user self-evaluation (MUSE) tool to identify Medicare Part D beneficiaries who would benefit from a comprehensive medication review. Methods: A random sample of 225 patient medication profiles was created from a survey of Medicare beneficiaries; the survey also included demographic characteristics, responses to adherence questions, and reported symptoms. Three clinical pharmacists used the patient profiles to make judgments regarding the likelihood (low, moderate, or high) that each patient would benefit from an MTM visit in the next 3 months. A total of 150 cases were used for model calibration, and 75 were used for validation. Ordinal logistic regression models were fit to predict the likelihood of benefit from an MTM visit by using different combinations of potential MUSE items. Final model selection was based on the Akaike information criterion and the percent agreement between model prediction and expert judgments in the validation data. Measures considered for inclusion in the MUSE tool were related to medication use, medical conditions, and health care utilization. Results: The final MUSE items incorporated number of medications, number of physicians, number of pharmacies, number of hospitalizations in the past 6 months, having forgotten to take medications, cost-related problems, and number of medical conditions. Conclusion: The 7-item MUSE tool could be used in targeting MTM services, such as comprehensive medication reviews, among Medicare beneficiaries.",
keywords = "Comprehensive medication review, Medicare, Medication therapy management, Tool",
author = "Doucette, {William R.} and Chang, {Elizabeth H.} and Pendergast, {Jane F.} and Wright, {Kara B.} and Chrischilles, {Elizabeth A.} and Farris, {Karen B.}",
year = "2013",
month = "3",
doi = "10.1016/j.clinthera.2013.02.010",
language = "English",
volume = "35",
pages = "344--350",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "3",

}

TY - JOUR

T1 - Development and Initial Assessment of the Medication User Self-Evaluation (MUSE) Tool

AU - Doucette, William R.

AU - Chang, Elizabeth H.

AU - Pendergast, Jane F.

AU - Wright, Kara B.

AU - Chrischilles, Elizabeth A.

AU - Farris, Karen B.

PY - 2013/3

Y1 - 2013/3

N2 - Background: Using patient-reported data to supplement claims-based indicators may be helpful in identifying Medicare beneficiaries likely to benefit from medication therapy management (MTM) services. Objective: Our objective was to develop and initially assess a patient medication user self-evaluation (MUSE) tool to identify Medicare Part D beneficiaries who would benefit from a comprehensive medication review. Methods: A random sample of 225 patient medication profiles was created from a survey of Medicare beneficiaries; the survey also included demographic characteristics, responses to adherence questions, and reported symptoms. Three clinical pharmacists used the patient profiles to make judgments regarding the likelihood (low, moderate, or high) that each patient would benefit from an MTM visit in the next 3 months. A total of 150 cases were used for model calibration, and 75 were used for validation. Ordinal logistic regression models were fit to predict the likelihood of benefit from an MTM visit by using different combinations of potential MUSE items. Final model selection was based on the Akaike information criterion and the percent agreement between model prediction and expert judgments in the validation data. Measures considered for inclusion in the MUSE tool were related to medication use, medical conditions, and health care utilization. Results: The final MUSE items incorporated number of medications, number of physicians, number of pharmacies, number of hospitalizations in the past 6 months, having forgotten to take medications, cost-related problems, and number of medical conditions. Conclusion: The 7-item MUSE tool could be used in targeting MTM services, such as comprehensive medication reviews, among Medicare beneficiaries.

AB - Background: Using patient-reported data to supplement claims-based indicators may be helpful in identifying Medicare beneficiaries likely to benefit from medication therapy management (MTM) services. Objective: Our objective was to develop and initially assess a patient medication user self-evaluation (MUSE) tool to identify Medicare Part D beneficiaries who would benefit from a comprehensive medication review. Methods: A random sample of 225 patient medication profiles was created from a survey of Medicare beneficiaries; the survey also included demographic characteristics, responses to adherence questions, and reported symptoms. Three clinical pharmacists used the patient profiles to make judgments regarding the likelihood (low, moderate, or high) that each patient would benefit from an MTM visit in the next 3 months. A total of 150 cases were used for model calibration, and 75 were used for validation. Ordinal logistic regression models were fit to predict the likelihood of benefit from an MTM visit by using different combinations of potential MUSE items. Final model selection was based on the Akaike information criterion and the percent agreement between model prediction and expert judgments in the validation data. Measures considered for inclusion in the MUSE tool were related to medication use, medical conditions, and health care utilization. Results: The final MUSE items incorporated number of medications, number of physicians, number of pharmacies, number of hospitalizations in the past 6 months, having forgotten to take medications, cost-related problems, and number of medical conditions. Conclusion: The 7-item MUSE tool could be used in targeting MTM services, such as comprehensive medication reviews, among Medicare beneficiaries.

KW - Comprehensive medication review

KW - Medicare

KW - Medication therapy management

KW - Tool

UR - http://www.scopus.com/inward/record.url?scp=84874992357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874992357&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2013.02.010

DO - 10.1016/j.clinthera.2013.02.010

M3 - Article

C2 - 23453405

AN - SCOPUS:84874992357

VL - 35

SP - 344

EP - 350

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 3

ER -